May 14, 2020
Lockheed Martin Steps Up To Help Save Lives And Support Be The Match® During COVID-19
Apr 23, 2020
Be The Match® Donates 100,000 Swabs To Medical Facilities
Apr 07, 2020
Be The Match Launches #Couch2Cure Social Media Movement to Meet Urgent Demand for Marrow or Blood Stem Cell Transplants
Feb 21, 2020
Actinium Presents Positive Findings from Mid-Point Analysis of Pivotal SIERRA Trial of Iomab-B at 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT)
Feb 25, 2019
Actinium's Late Breaking Oral Presentation at 2019 TCT Meetings Reports New Data on Donor Chimerism Indicating Deep Engraftment in All Iomab-B Treated Patients in the Pivotal Phase 3 SIERRA Trial
Feb 22, 2019
Roswell Park Presentations at TCT Meeting Focus on Tools for Predicting Patient Outcomes
Oct 03, 2018
Be The Match BioTherapies® and Cryoport Announce Strategic Partnership to Deliver Integrated End-to-End Supply Chain Services to the Cell and Gene Therapy Industry
Feb 23, 2018
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease
Jan 17, 2018
Seattle Cancer Care Alliance Survival Rates among Top in U.S. for Fred Hutch Bone Marrow Transplant Program at SCCA
Oct 26, 2017
Omeros Reports Additional and Consistently Positive Data for OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
Aug 02, 2017
U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only Approved Treatment for Adult Patients with Chronic Graft-Versus-Host-Disease (cGVHD) After Failure of One or More Lines of Systemic Therapy
Jun 07, 2017
Transplant Community & Sickle Cell Disease Advocates Urge Congress to Advance Policies Supporting Sickle Cell Disease Research and Treatment